Behavioural effects of high fat diet in a mutant mouse model for the schizophrenia risk gene neuregulin 1

Genes, Brain and Behavior

Volumn 15, Issue 3, 2016, Pages 295-304

  Holm Hansen, S ^a,b   Low, J K ^c,d   Zieba, J ^c,d   Gjedde, A ^a,e   Bergersen, L H ^a,b,e   Karl, T ^c,d,f  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF OSLO   (Norway)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d Schizophrenia Research Institute   (Australia)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anxiety; Behaviour; Cognition; Fear associated memory; Gene environment interaction; Glucose tolerance; High fat diet; Hyperlocomotion; Mouse model; Neuregulin 1; Schizophrenia; Sensorimotor gating; Social preference

Indexed keywords

GLUCOSE; NEU DIFFERENTIATION FACTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AUDITORY RESPONSE; COGNITIVE DEFECT; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEAR CONDITIONING TEST; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERACTIVITY; IMPAIRED GLUCOSE TOLERANCE; INVESTIGATIVE PROCEDURES; LIPID DIET; LOCOMOTION; MOUSE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY GATING; SOCIAL RECOGNITION TEST; SOCIAL STATUS; STARTLE REFLEX; WEIGHT CHANGE; WEIGHT GAIN; WILD TYPE; ANIMAL; BODY WEIGHT; DIET THERAPY; DISEASE MODEL; GENETICS; INBRED MOUSE STRAIN; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; RISK FACTOR;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; LOCOMOTION; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NEUREGULIN-1; REFLEX, STARTLE; RISK FACTORS; SCHIZOPHRENIA; SENSORY GATING;

EID: 84959496796     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/gbb.12267     Document Type: Article

References (65)

1. Amminger, G.P., Schafer, M.R., Papageorgiou, K., Klier, C.M., Cotton, S.M., Harrigan, S.M., Mackinnon, A., McGorry, P.D. & Berger, G.E. (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67, 146-154.
2. Bayer, T.A., Falkai, P. & Maier, W. (1999) Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "Two hit hypothesis". J Psychiatr Res 33, 543-548.
3. Bellack, A.S., Morrison, R.L., Wixted, J.T. & Mueser, K.T. (1990) An analysis of social competence in schizophrenia. Br J Psychiatry 156, 809-818.
4. Bjarnadottir, M., Misner, D.L., Haverfield-Gross, S., Bruun, S., Helgason, V.G., Stefansson, H., Sigmundsson, A., Firth, D.R., Nielsen, B., Stefansdottir, R., Novak, T.J., Stefansson, K., Gurney, M.E. & Andresson, T. (2007) Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. J Neurosci 27, 4519-4529.
5. Boey, D., Lin, S., Karl, T., Baldock, P., Lee, N., Enriquez, R., Couzens, M., Slack, K., Dallmann, R., Sainsbury, A. & Herzog, H. (2006) Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 49, 1360-1370.
6. du Bois, T.M., Deng, C., Bell, W. & Huang, X.F. (2006) Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience 139, 1397-1403.
7. Boucher, A.A., Arnold, J.C., Duffy, L., Schofield, P.R., Micheau, J. & Karl, T. (2007a) Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol. Psychopharmacology (Berl) 192, 325-336.
8. Boucher, A.A., Hunt, G.E., Karl, T., Micheau, J., McGregor, I.S. & Arnold, J.C. (2007b) Heterozygous neuregulin 1 mice display greater baseline and Delta(9)-tetrahydrocannabinol-induced c-Fos expression. Neuroscience 149, 861-870.
9. Boucher, A.A., Hunt, G.E., Micheau, J., Huang, X., McGregor, I.S., Karl, T. & Arnold, J.C. (2011) The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. Int J Neuropsychopharmacol 14, 631-643.
10. Bredin, S.S.D., Warburton, D.E.R. & Lang, D.J. (2013) The health benefits and challenges of exercise training in persons living with schizophrenia: a pilot study. Brain Sci 3, 821-848.
11. Britvic, D., Maric, N.P., Doknic, M., Pekic, S., Andric, S., Jasovic-Gasic, M. & Popovic, V. (2013) Metabolic issues in psychotic disorders with the focus on first-episode patients: a review. Psychiatr Danub 25, 410-415.
12. Buchenauer, T., Behrendt, P., Bode, F.J., Horn, R., Brabant, G., Stephan, M. & Nave, H. (2009) Diet-induced obesity alters behavior as well as serum levels of corticosterone in F344 rats. Physiol Behav 98, 563-569.
13. Cadenhead, K.S., Geyer, M.A. & Braff, D.L. (1993) Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. Am J Psychiatry 150, 1862-1867.
14. Caspi, A. & Moffitt, T.E. (2006) Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7, 583-590.
15. Cheng, D., Low, J.K., Logge, W., Garner, B. & Karl, T. (2014a) Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1ΔE9 mice. Psychopharmacology (Berl) 231, 3009-3017.
16. Cheng, D., Low, J.K., Logge, W., Garner, B. & Karl, T. (2014b) Novel behavioural characteristics of female APPSwe/PS1ΔE9 double transgenic mice. Behav Brain Res 260, 111-118.
17. Chesworth, R., Downey, L., Logge, W., Killcross, S. & Karl, T. (2012a) Cognition in female transmembrane domain neuregulin 1 mutant mice. Behav Brain Res 226, 218-223.
18. Chesworth, R., Yulyaningsih, E., Cappas, E., Arnold, J., Sainsbury, A. & Karl, T. (2012b) The response of neuregulin 1 mutant mice to acute restraint stress. Neurosci Lett 515, 82-86.
19. Condray, R. & Yao, J.K. (2011) Cognition, dopamine and bioactive lipids in schizophrenia. Front Biosci (Schol Ed) 3, 298-330.
20. Corriveau, J.A. & Glenn, M.J. (2012) Postnatal choline levels mediate cognitive deficits in a rat model of schizophrenia. Pharmacol Biochem Behav 103, 60-68.
21. Csomor, P.A., Yee, B.K., Vollenweider, F.X., Feldon, J., Nicolet, T. & Quednow, B.B. (2008) On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav Neurosci 122, 885-900.
22. Dipasquale, S., Pariante, C.M., Dazzan, P., Aguglia, E., McGuire, P. & Mondelli, V. (2013) The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res 47, 197-207.
23. Duffy, L., Cappas, E., Lai, D., Boucher, A.A. & Karl, T. (2010) Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 170, 800-807.
24. Enez Darcin, A., Yalcin Cavus, S., Dilbaz, N., Kaya, H. & Dogan, E. (2015) Metabolic syndrome in drug-naive and drug-free patients with schizophrenia and in their siblings. Schizophr Res 166, 201-206.
25. Francis, H. & Stevenson, R. (2013) The longer-term impacts of Western diet on human cognition and the brain. Appetite 63, 119-128.
26. Gama, C.S., Canever, L., Panizzutti, B., Gubert, C., Stertz, L., Massuda, R., Pedrini, M., de Lucena, D.F., Luca, R.D., Fraga, D.B., Heylmann, A.S., Deroza, P.F. & Zugno, A.I. (2012) Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia. Schizophr Res 141, 162-167.
27. Geyer, M.A. & Dulawa, S.C. (2003) Assessment of murine startle reactivity, prepulse inhibition, and habituation. Curr Protoc Neurosci, Chapter 8, Unit 8.17. 8.17.1-8.17.15.
28. Hedelin, M., Lof, M., Olsson, M., Lewander, T., Nilsson, B., Hultman, C.M. & Weiderpass, E. (2010) Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33, 000 women from the general population. BMC Psychiatry 10, 38.
29. Henderson, D.C., Borba, C.P., Daley, T.B., Boxill, R., Nguyen, D.D., Culhane, M.A., Louie, P., Cather, C., Eden Evins, A., Freudenreich, O., Taber, S.M. & Goff, D.C. (2006) Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry 18, 99-105.
30. Kanoski, S.E. & Davidson, T.L. (2010) Different patterns of memory impairments accompany short- and longer-term maintenance on a high-energy diet. J Exp Psychol Anim Behav Process 36, 313-319.
31. Karl, T. (2013) Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models. Front Behav Neurosci 7, 106.
32. Karl, T. & Arnold, J.C. (2014) Schizophrenia: a consequence of gene-environment interactions? Front Behav Neurosci 8, 435.
33. Karl, T., Duffy, L., Scimone, A., Harvey, R.P. & Schofield, P.R. (2007) Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav 6, 677-687.
34. Karl, T., Burne, T.H.J., van den Buuse, M. & Chesworth, R. (2011) Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit? Behav Brain Res 223, 336-341.
35. Knight, E.M., Martins, I.V., Gumusgoz, S., Allan, S.M. & Lawrence, C.B. (2014) High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging 35, 1821-1832.
36. Kohsaka, A., Laposky, A.D., Ramsey, K.M., Estrada, C., Joshu, C., Kobayashi, Y., Turek, F.W. & Bass, J. (2007) High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 6, 414-421.
37. Kraft, B.D. & Westman, E.C. (2009) Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. Nutr Metab (Lond) 6, 10.
38. Labouesse, M.A., Stadlbauer, U., Langhans, W. & Meyer, U. (2013) Chronic high fat diet consumption impairs sensorimotor gating in mice. Psychoneuroendocrinology 38, 2562-2574.
39. Logge, W., Kingham, J. & Karl, T. (2013) Behavioural consequences of IVC cages on male and female C57BL/6J mice. Neuroscience 237, 285-293.
40. Logge, W., Kingham, J. & Karl, T. (2014) Do individually ventilated cage systems generate a problem for genetic mouse model research? Genes Brain Behav 13, 713-720.
41. Long, L.E., Chesworth, R., Arnold, J.C. & Karl, T. (2010) A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant mice. Psychopharmacology (Berl) 211, 277-289.
42. Long, L.E., Chesworth, R., Huang, X.-F., McGregor, I.S., Arnold, J.C. & Karl, T. (2013) Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. Int J Neuropsychopharmacol 16, 163-175.
43. Mizunoya, W., Ohnuki, K., Baba, K., Miyahara, H., Shimizu, N., Tabata, K., Kino, T., Sato, Y., Tatsumi, R. & Ikeuchi, Y. (2013) Effect of dietary fat type on anxiety-like and depression-like behavior in mice. Springerplus 2, 165.
44. Morrison, C.D., Pistell, P.J., Ingram, D.K., Johnson, W.D., Liu, Y., Fernandez-Kim, S.O., White, C.L., Purpera, M.N., Uranga, R.M., Bruce-Keller, A.J. & Keller, J.N. (2010) High fat diet increases hippocampal oxidative stress and cognitive impairment in aged mice: implications for decreased Nrf2 signaling. J Neurochem 114, 1581-1589.
45. Murphy, B.P., Chung, Y.-C., Park, T.-W. & McGorry, P.D. (2006) Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr Res 88, 5-25.
46. Ohara, K. (2007) The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31, 469-474.
47. O'Tuathaigh, C.M., Babovic, D., O'Sullivan, G.J., Clifford, J.J., Tighe, O., Croke, D.T., Harvey, R. & Waddington, J.L. (2007) Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1. Neuroscience 147, 18-27.
48. Peet, M. (2004) Diet, diabetes and schizophrenia: review and hypothesis. Br J Psychiatry Suppl 47, S102-S105.
49. Perneger, T.V. (1998) What's wrong with Bonferroni adjustments. BMJ 316, 1236-1238.
50. Powell, C.M. & Miyakawa, T. (2006) Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry 59, 1198-1207.
51. Rothman, K.J. (1990) No adjustments are needed for multiple comparisons. Epidemiology 1, 43-46.
52. Ryan, M.C., Collins, P. & Thakore, J.H. (2003) Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 160, 284-289.
53. Salomons, A.R., Arndt, S.S. & Ohl, F. (2012) Impact of anxiety profiles on cognitive performance in BALB/c and 129P2 mice. Cogn Affect Behav Neurosci 12, 794-803.
54. Scott, K.M., Bruffaerts, R., Simon, G.E., Alonso, J., Angermeyer, M., de Girolamo, G., Demyttenaere, K., Gasquet, I., Haro, J.M., Karam, E., Kessler, R.C., Levinson, D., Medina Mora, M.E., Oakley Browne, M.A., Ormel, J., Villa, J.P., Uda, H. & Von Korff, M. (2008) Obesity and mental disorders in the general population: results from the world mental health surveys. Int J Obes (Lond) 32, 192-200.
55. Sharma, S. & Fulton, S. (2013) Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int J Obes (Lond) 37, 382-389.
56. Sigurdsson, T., Doyere, V., Cain, C.K. & LeDoux, J.E. (2007) Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory. Neuropharmacology 52, 215-227.
57. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V. et al. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71, 877-892.
58. Stokes, C. & Peet, M. (2004) Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms. Nutr Neurosci 7, 247-249.
59. Tsuruga, K., Sugawara, N., Sato, Y., Saito, M., Furukori, H., Nakagami, T., Nakamura, K., Takahashi, I., Nakaji, S. & Yasui-Furukori, N. (2015) Dietary patterns and schizophrenia: a comparison with healthy controls. Neuropsychiatr Dis Treat 11, 1115-1120.
60. Uzbekov, M.G., Misionzhnik, E., Gurovich, I., Shmukler, A. & Moskvitina, T. (2013) Aspects of metabolic changes in first-episode drug-naive schizophrenic patients. Acta Neuropsychiatr 25, 268-274.
61. Verma, S.K., Subramaniam, M., Liew, A. & Poon, L.Y. (2009) Metabolic risk factors in drug-naive patients with first-episode psychosis. J Clin Psychiatry 70, 997-1000.
62. Wang, J., Fan, X., Liu, D., Yi, Z., Freudenreich, O., Goff, D. & Henderson, D.C. (2012) Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia. Schizophr Res 140, 260-261.
63. Winzell, M.S. & Ahren, B. (2004) The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53 (Suppl. 3), S215-S219.
64. Wong, C.K., Botta, A., Pither, J., Dai, C., Gibson, W.T. & Ghosh, S. (2015) A high-fat diet rich in corn oil reduces spontaneous locomotor activity and induces insulin resistance in mice. J Nutr Biochem 26, 319-326.
65. Wu, X., Huang, Z., Han, H., Zhong, Z., Gan, Z., Guo, X., Diao, F., Han, Z. & Zhao, J. (2014) The comparison of glucose and lipid metabolism parameters in drug-naive, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia. Neuropsychiatr Dis Treat 10, 1361-1368.